Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Infants.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck's CAPVAXIVE (Pneumo. 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Adults with Increased Risk for Pneumococcal Disease.
Merck (MRK) Rises As Market Takes a Dip: Key Facts
07:01pm, Tuesday, 15'th Oct 2024
The latest trading day saw Merck (MRK) settling at $111.53, representing a +1.68% change from its previous close.
Exelixis, MRK Collaborate for Combination Studies on HNSCC and RCC
10:00am, Tuesday, 15'th Oct 2024
EXEL is set to evaluate investigational zanzalintinib in combination with Merck;s Keytruda (pembrolizumab) and Welireg in head and neck cancer and renal cell carcinoma, respectively.
Buy 7 Sustainable Dividend Dogs From Barron's October 100
12:56pm, Monday, 14'th Oct 2024
Barron's seventh-annual (2024) ranking of Sustainable companies started with the 1,000 largest publicly traded companies by market value, then ranked each by performance for five key constituencies: s
ALAMEDA, Calif. & RAHWAY, N.J.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the companies have ente
Best Pharma Stocks for Long-Term Investors: Growth and Dividends
07:01am, Monday, 14'th Oct 2024
The size of the pharmaceutical industry in the U.S. in 2023 was estimated to be nearly $575 billion, with an anticipated compound growth rate of about 5.5% through 2030. This key component of the heal
5 Blue Chip Dividend Stocks to Own If You Had to Hold Them Forever
02:40pm, Sunday, 13'th Oct 2024
24/7 Wall St. Insights Dividend stocks will get a solid tailwind from falling interest rates.
2 Incredibly Cheap Big Pharma Stocks to Buy Now
06:10am, Saturday, 12'th Oct 2024
There's doubtlessly some coming uncertainty for both, but the prices are right.
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Friday, 11'th Oct 2024
Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
New Data to be Presented at IDWeek 2024 Reinforce Merck's Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio
06:45am, Wednesday, 09'th Oct 2024
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--New Data to be Presented at IDWeek 2024 Reinforce Merck's Broad and Diverse Vaccines and Infectious Disease Pipeline and Portfolio.
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Activated Polyethylene Glycol Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offerin
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA® (pembroli
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Flavonoids Market Report by Type, Form, Application, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global flavono
Merck Is At Support And Should Go Higher (Technical Analysis)
02:39am, Monday, 07'th Oct 2024
Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level that is likely to hold. Keytruda remains a key revenue driver, with potential for continue
